To be fined 2.6 million yuan! A drug company in Zhengzhou to inflate the price of ibuprofen tablets was investigated

Read Time:2 Minute, 53 Second

December 29, Dahe – Yu video reporter learned from the Zhengzhou Municipal Bureau of Market Supervision, recently, Zhengzhou Municipal Bureau of Market Supervision, law enforcement inspection detachment to carry out antipyretic, cough, antibiotics, antiviral and other “four types” of drugs and antigen detection reagents and other epidemic-related materials enforcement special action, according to the law to investigate and handle a number of cases involving price inflating, hoarding, illegal sales. Ltd. was given a warning and fined 2.6 million yuan as administrative punishment for disturbing the price order of the market of epidemic-related materials.

On December 27, Zhengzhou Municipal Market Supervision Bureau enforcement inspection detachment according to the law investigated and punished Zhengzhou “small medicine medicine” Pharmaceutical Technology Co. Through the online “Medicine Help” App wholesale platform, the party adopted B2B model to inflate the price of ibuprofen tablets to pharmaceutical retailers, pharmacies and clinics nationwide, and after two price increases, the price of ibuprofen tablets sold by the company rose from RMB2.33/bottle to RMB2.43/bottle on December 10, 2022, to RMB2.33/bottle on December 17, 2022 to RMB2.43/bottle on December 17, 2022. The price of ibuprofen tablets sold by the company increased from RMB 2.33/bottle-2.43/bottle on December 10, 2022 to RMB 19.8/bottle between December 17, 2022 and December 24, 2022. Because the number of drugs involved in the case amounted to 30,600 bottles, which directly led to a large number of terminal drug retail enterprises and medical institutions about the drug prices increased significantly, disrupting the price order of the market of epidemic-related materials, with a bad social impact. After investigation, it was found that Zhengzhou “Small Medicine” Pharmaceutical Technology Co., Ltd. had substantially increased the sales price under the condition that the purchase cost remained unchanged, which allegedly constituted the illegal act of price gouging.

December 29, Zhengzhou Municipal Bureau of Market Supervision in accordance with the “Price Law of the People’s Republic of China” and “administrative punishment for price violations,” the relevant provisions of the comprehensive consideration of the facts, circumstances and social harm, the parties have been ordered to immediately correct the situation, and served a notice of administrative penalty to the parties, to be given a warning, a fine of 2.6 million yuan of administrative penalties.

Zhengzhou Municipal Bureau of Market Supervision solemnly reminded: the drug and medical device operators should strictly implement the main responsibility to comply with the law, and effectively strengthen price self-discipline, no hoarding, price gouging, price fraud and other price violations, to achieve strict self-discipline, operate in accordance with the law, clear price, standardize business, fulfill commitments, integrity.

Market supervision department once found to take the opportunity to raise prices, arbitrary price increases and other price gouging behavior, will resolutely investigate and punish according to the law from the heavy and fast, and in conjunction with the relevant departments to implement joint disciplinary action to maximize the protection of the rights and interests of the people, to maintain a smooth market.

Welcome the masses and the community to supervise the behavior of operators, such as the discovery of price violations, please promptly retain key evidence, and can call 12315 hotline or login to the national 12315 platform website, applet, public number for complaints and reports, Zhengzhou Municipal Bureau of Market Supervision will be investigated and dealt with in a timely manner in accordance with the law.